Search

everythinglearnresearchcommunity

for

Search:↓

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Bald men are not more virile and may have fewer sexual partners.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Men with self-diagnosed PFS-related ED have normal erectile hemodynamics.

Finasteride increases risk of depression, possibly suicidal thoughts, and sexual dysfunction.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

The conclusion is that more research is needed to understand if the drug finasteride causes Post-Finasteride Syndrome or if it's due to individual genetic makeup.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Finasteride use in young men with hair loss is linked to sexual dysfunction.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Finasteride may cause long-lasting sexual side effects.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Finasteride helps reduce priapism in sickle cell anemia patients.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.